Heyman Tomas J., a director at Exelixis, Inc. ($EXEL), made one open market sale of $EXEL shares in the last year, totaling $201,254, with the most recent on May 21, 2025. These sales rank 8,389th among 11,678 individual insiders, below the average sale amount of $8.6 million and 6.4 transactions per insider. He had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Heyman Tomas J. | Not found | D | Common Stock | 9398 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Heyman Tomas J. | Not found | D | Stock Option (Right to Buy) | 13000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Heyman Tomas J. | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Heyman Tomas J. | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Heyman Tomas J. | Not found | D | Stock Option (Right to Buy) | 26000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.03% |
| June 3, 2025 | Akero Therapeutics, Inc. | $AKRO | Heyman Tomas J. | Not found | A | Common Stock | 9398 | $0.00 | 9,398.0000 | 79,620,128 | 9999.99% | 0.01% |
| May 29, 2025 | EXELIXIS, INC. | $EXEL | Heyman Tomas J. | Director | A | Common Stock | 9812 | $0.00 | 42,282.0000 | 296,132,000 | 30.22% | 0.00% |
| May 21, 2025 | EXELIXIS, INC. | $EXEL | Heyman Tomas J. | Director | S | Common Stock | 4544 | $44.29 | 32,470.0000 | 296,132,000 | 12.28% | 0.00% |
| June 8, 2024 | Akero Therapeutics, Inc. | $AKRO | Heyman Tomas J. | Not found | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2024 | EXELIXIS, INC. | $EXEL | Heyman Tomas J. | Director | A | Common Stock | 18838 | $0.00 | 37,014.0000 | 321,464,000 | 103.64% | 0.01% |
| May 31, 2023 | EXELIXIS, INC. | $EXEL | Heyman Tomas J. | Director | A | Option (right to buy) | 36353 | $0.00 | 36,353.0000 | 324,556,000 | 9999.99% | 0.01% |
| May 31, 2023 | EXELIXIS, INC. | $EXEL | Heyman Tomas J. | Director | A | Common Stock | 18176 | $0.00 | 18,176.0000 | 324,556,000 | 9999.99% | 0.01% |